APA (7th ed.) Citation

Moon, J. S., Kim, N. H., Na, J. O., Cho, J. H., Jeong, I., Lee, S. H., . . . Won, K. C. (2023). Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing Surveillance. Diabetes & Metabolism Journal, 47(1), 82. https://doi.org/10.4093/dmj.2021.0356

Chicago Style (17th ed.) Citation

Moon, Jun Sung, et al. "Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing Surveillance." Diabetes & Metabolism Journal 47, no. 1 (2023): 82. https://doi.org/10.4093/dmj.2021.0356.

MLA (9th ed.) Citation

Moon, Jun Sung, et al. "Safety and Effectiveness of Empagliflozin in Korean Patients with Type 2 Diabetes Mellitus: Results from a Nationwide Post-Marketing Surveillance." Diabetes & Metabolism Journal, vol. 47, no. 1, 2023, p. 82, https://doi.org/10.4093/dmj.2021.0356.